Novel proteins and use thereof
CA 2511522 A1 · Owner: Sato, Shuji · Inventors: Sato, Shuji; Yamamoto, Koji; Sunahara, Eiji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound inhibiting the expression of a protein having an amino acid sequence which is the same or substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID NO:4 SEQ ID NO:7 or SEQ ID O:10 or the , expression of a gene of the protein an antisense polynucleotide having a base sequence which is complementary or substantially complementary to the base sequence of DNA encoding the above protein or its peptide fragment or a part of the above base sequence, an antibody against the above protein or its peptide fragment, etc. are useful as preventives or remedies for cancer etc. apoptosis promoters and so on.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 25, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 25, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 25, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.